uToronto startup receives $4 M for cancer-analyzing software

March 3, 2016

The University of Toronto startup Pathcore has received a $4 M investment from the US-based National Cancer Institute to develop and implement Pathcore’s technology. The money will be used specifically to develop Pathcore's tissue analysis software through six major cancer centres in Canada and the US, with the hope that this software will significantly reduce the time traditionally needed to detect cancer in medical samples. “We free pathologists from counting cells, searching for those hard-to-find areas through a microscope, and doing other repetitive tasks that software can do faster and better,” said Pathcore Co-founder and CEO Dan Hosseinzadeh, "ultimately, that means improved patient care.” uToronto